{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/04/30/3284839/0/en/Pliant-Therapeutics-Announces-First-Patient-Dosed-in-FORTIFY-the-Phase-1b-Indication-Expansion-Trial-Evaluating-PLN-101095-in-Patients-with-ICI-Refractory-Solid-Tumors.html", "message": "News view counter 693065 successfully enlarged"}